EIF4EBP1 and familial pancreatic carcinoma: In summary, we show that mTOR inhibition results in the feedback activation of translation programs in 4EBP1 lacking pancreatic cancer cells, and targeting translation downstream of mTOR may be a better therapeutic strategy in pancreatic cancer.